FDA panel gives nod to Bayer/J&J anti-clot drug
by on Sep.13, 2011, under Health and Fitness
A new stroke preventer from Bayer and Johnson & Johnson moved one step closer to U.S. approval, but questions remained about restrictions on labeling and the need for more studies.
View full post on Yahoo! Health News
